Enlaza Therapeutics

Enlaza

This biotechnology company develops covalent protein medicines using a synthetic biology platform to treat patients with cancer and other serious diseases.

Matchpoint Therapeutics

This biotechnology company develops oral covalent small molecule medicines to treat patients with autoimmune and inflammatory diseases.

HYKU Biosciences

This biotechnology company develops precision covalent small-molecule medicines targeting disease-driving proteins to treat patients with cancer and other illnesses.

Catena Bio

This biotechnology firm develops protein conjugation technology and multi-payload therapeutic conjugates for biopharmaceutical companies to treat oncology and autoimmune diseases.

Enodia

This company develops small-molecule therapies that degrade disease-causing proteins at the point of synthesis for patients with cancer and inflammatory diseases.

Ligature Therapeutics

This biotech company develops protein degrader therapeutics using a fragment-based discovery platform to treat intractable diseases for patients with cancer.

LTZ Therapeutics

This biopharma company develops myeloid engager immunotherapies for patients with cancer and autoimmune diseases.

Hummingbird Bioscience

This company develops antibody-based therapeutics and drug conjugates for patients with hard-to-treat cancers and autoimmune diseases.